Capital Investment Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History

Capital Investment Advisory Services’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$962K	Sell	19,771 -2,581	-12%	-$126K	0.08%	232
2025 Q1	$761K	Buy	22,352 +87	+0.4%	+$2.96K	0.07%	252
2024 Q4	$876K	Sell	22,265 -2,994	-12%	-$118K	0.08%	206
2024 Q3	$1.19M	Sell	25,259 -4,727	-16%	-$222K	0.11%	178
2024 Q2	$1.62M	Sell	29,986 -118	-0.4%	-$6.37K	0.17%	129
2024 Q1	$2.05M	Sell	30,104 -1,532	-5%	-$104K	0.22%	106
2023 Q4	$1.98M	Buy	31,636 +855	+3%	+$53.5K	0.18%	100
2023 Q3	$1.4M	Buy	30,781 +925	+3%	+$42K	0.14%	139
2023 Q2	$1.68M	Buy	29,856 +483	+2%	+$27.1K	0.17%	107
2023 Q1	$1.33M	Buy	29,373 +2,108	+8%	+$95.3K	0.16%	132
2022 Q4	$1.11M	Sell	27,265 -2,056	-7%	-$83.6K	0.13%	148
2022 Q3	$1.92M	Buy	29,321 +1,092	+4%	+$71.4K	0.25%	80
2022 Q2	$1.72M	Buy	28,229 +1,242	+5%	+$75.5K	0.21%	96
2022 Q1	$1.69M	Buy	26,987 +6,591	+32%	+$414K	0.18%	109
2021 Q4	$1.55M	Sell	20,396 -1,688	-8%	-$128K	0.18%	124
2021 Q3	$2.47M	Sell	22,084 -529	-2%	-$59.2K	0.31%	65
2021 Q2	$3.66M	Buy	22,613 +1,858	+9%	+$301K	0.46%	49
2021 Q1	$2.53M	Buy	20,755 +4,025	+24%	+$490K	0.36%	66
2020 Q4	$2.56M	Sell	16,730 -5,332	-24%	-$817K	0.38%	59
2020 Q3	$1.85M	Sell	22,062 -4,775	-18%	-$399K	0.35%	70
2020 Q2	$1.97M	Buy	26,837 +2,394	+10%	+$176K	0.4%	62
2020 Q1	$1.04M	Buy	24,443 +935	+4%	+$39.7K	0.25%	87
2019 Q4	$1.43M	Sell	23,508 -65	-0.3%	-$3.96K	0.38%	54
2019 Q3	$966K	Sell	23,573 -695	-3%	-$28.5K	0.27%	76
2019 Q2	$1.2M	Buy	24,268 +1,414	+6%	+$69.9K	0.36%	51
2019 Q1	$816K	Sell	22,854 -2,425	-10%	-$86.6K	0.3%	62
2018 Q4	$722K	Buy	25,279 +8,376	+50%	+$239K	0.31%	63
2018 Q3	$750K	Sell	16,903 -1,060	-6%	-$47K	0.35%	73
2018 Q2	$1.06M	Buy	17,963 +3,803	+27%	+$224K	0.53%	43
2018 Q1	$647K	Buy	14,160 +3,860	+37%	+$176K	0.36%	71
2017 Q4	$242K	Sell	10,300 -500	-5%	-$11.7K	0.14%	153
2017 Q3	$193K	Buy	+10,800	New	+$193K	0.12%	166